Nowadays, LY3502790 and PF-06882961 (231233), a class of oral non-peptide small molecule GLP-1RAs with preferable efficacy and anti-diabetes potential, are at the stage of pre-clinical research
General clinical guidance for adults on GLP-1 therapy often falls in the range of 1.21.6 grams of protein per kilogram of body weight per day, though your care team should help you personalize this based on your weight, activity level, and medication
Science Day is set for September 4, 2024
GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine
Richard Anderson, Professor at UW-Madsion
PT-141 should not be injected more than twice a week or eight times per month, Staheli cautions